GSK introduces Breathe Right Nasal Strips to the Middle East Region

A solution for 34% of adults suffering from night-time breathing problems

GlaxoSmithKline (GSK), a world leader in healthcare, introduced to the Middle East market Breathe Right Nasal Strips as a solution to the growing adults breathing problems, especially while sleeping, which is negatively affecting their ability to get a deep and restful sleep.

GSK has identified earlier the major reasons behind this condition, which include nasal congestion and deviated septum, and presented Breathe Right Nasal Strips, a clinically proven product, that gently lifts up nasal passages and instantly improve airflow by up to 31% to relieve nasal congestion and reduce snoring for a better night of sleep.

A recent consumer research conducted by GSK in Saudi Arabia reveals that sleep quality is significantly related to breathing where 34% of respondents reported experiencing breathing problems during sleep. No less than 20% listed breathing problems as the most frequently experienced physical ailments during sleep. Additionally, 24% of respondents reported suffering from snoring and 12% reported having bed partner who snore and disturbs their sleep. The study also found that males are more likely to experience breathing difficulties, snoring, and nasal congestion while females are more likely to be affected by partner’s snoring.

Interrupted sleep results in negative effects on people’s mood and behaviour including stress, depression, agitation, anger, sadness and anxiety.

Breathe Right is a elastic strip that sticks to the skin and gently lifts up both sides of the nose thanks to its spring-like action. It is a drug free product that does not require a doctor’s prescription; therefore, it can also be used by pregnant women and can be easily and rapidly applied by users.

Another global research by GSK shows that Breathe Right improved breathing in 75% of snorers and 90% of users reported improved sleep quality and less sleeping during the day.